Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection (Q45358078)

13 December 2017

title

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection (English)

1 reference

13 December 2017

0 references

9

Martin F Bachmann

1 reference

13 December 2017

8

Philippe Saudan

1 reference

13 December 2017

4

Andrea Jegerlehner

1 reference

13 December 2017

Nicole Schmitz

1

1 reference

13 December 2017

Roger R Beerli

2

1 reference

13 December 2017

Monika Bauer

3

1 reference

13 December 2017

Klaus Dietmeier

5

1 reference

13 December 2017

Melanie Maudrich

6

1 reference

13 December 2017

Paul Pumpens

7

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

European Journal of Immunology

13 December 2017

published in

1 reference

13 December 2017

volume

42

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

863-869

1 reference

The biology of influenza viruses

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Cell-mediated protection in influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Declining T-cell immunity to influenza, 1977-82

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Isolation of human monoclonal antibodies by mammalian cell display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Fc-receptors as regulators of immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Versatile virus-like particle carrier for epitope based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

Mass vaccination for annual and pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

TLR9 signaling in B cells determines class switch recombination to IgG2a

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041225

7 January 2021

Identifiers

DOI

10.1002/EJI.201041225

1 reference

13 December 2017

1 reference